NVIDIA Corp (NASDAQ:NVDA, ETR:NVD) is expected to once again deliver upside against high expectations when the chipmaker posts its latest earnings report after the stock market closes on Wednesday.
For the quarter ended July 28, Wall Street analysts expect revenue to surge more than 110% year-over-year to $28.4 billion, in line with Nvidia’s guidance at the midpoint of $28 billion.
Seeing Machines Ltd's (AIM:SEE, OTC:SEEMF) trading update passed muster with investment bank Stifel, which restated its 'buy' advice and 13p a share price target.
In afternoon trading the stock was trading sideways at 5.1p after the driver safety specialist said revenues for the financial year to June 30 would be in the order of $67.6 million.
The surge in GLP-1 obesity-related research is highlighting a critical shift in medical literature, according to a recent analysis by Deutsche Bank.
It notes that managing obesity is becoming increasingly vital, with terms like "diabesity"—the intersection of diabetes and obesity—gaining traction since 2023.
Hochschild Mining PLC (LSE:HOC, OTCQX:HCHDF) slumped on Wednesday after a seemingly positive set of interims failed to enthuse investors.
Revenue climbed 25% to US$391.7 million over the first half of the year, the firm reported on Wednesday, while adjusted earnings jumped 78% to US$177.1 million.
Direct Line Insurance Group PLC (LSE:DLG) has been upgraded to a buy by US group Citi with the target price being raised to 223p irrespective of the motor insurance pricing cycle.
Shares are down 12% since the end of May but Citi sees the underlying motor trends as favourable with UK Motor claims improving, but the US bank sees a big contribution from non-motor.
In 2021, global insurance giant Prudential plc made a bet-the-farm decision to ditch its US and European operations to focus on the emerging middle classes of the Asian continent.
Today’s interim results, though they had their bright spots, suggest that Prudential’s big bet “isn’t playing out as the company would have hoped”, per AJ Bell’s investment director Russ Mould’s analysis.
How does a benchmark consumer staples giant like Nestle S.A. (OTC:NSRGF, VTX:NESN) reset the agenda and return to growth after a period of losing market share to global competitors like Unilever and Danone (OTCQX:DANOY)?
For Barclays, replacing the chief executive, as Nestle did this week with the ascension of long-time vice president Laurent Freixe, is a start but certainly not the end.
B&Q owner Kingfisher PLC (LSE:KGF) took a hit on Wednesday after Citigroup analysts downgraded the company, citing weakness in overseas markets.
“We continue to see scope for stronger UK outlook on the back of healthy consumer sentiment trends and higher housing market activity in 2025 and 2026,” the bank said.
GSK PLC (LSE:GSK, NYSE:GSK) shares opened higher after Delaware's Supreme Court said it will hear an appeal by the UK drug market and other pharmaceutical companies, including Pfizer, Sanofi, and Boehringer Ingelheim, to dismiss over 70,000 lawsuits alleging that the discontinued heartburn drug Zantac causes cancer.
The companies argue that the scientific methods used by plaintiffs to link Zantac to cancer are unsound.